FDA Approves Enhertu for HER2-Positive Solid Tumors

New Study Reveals HPV Vaccine Benefits Men, Too

Findings underscore vaccine's effectiveness in preventing not only cervical cancer but also head and neck cancers in males

Percutaneous Hepatic Perfusion Should Be Done First and Early for Metastatic Uveal Melanoma Patients

The pivotal phase III FOCUS study shows percutaneous hepatic perfusion (PHP) is best option

New Combination Therapy Brings Hope to Bladder Cancer Patients

Innovative treatment shows high success rates in overcoming standard therapy resistance

Using First-of-its-Kind Vaccine to Treat Leptomeningeal Disease

Dendritic cell vaccine may prolong survival well past dismal prognosis

Personalized Vaccine Shows Promise in Merkel Cell Carcinoma

More than half of patients responded to checkpoint inhibitor rechallenge following treatment with vaccine containing streptococcus bacterial antigen

Could a Quick Electronic Assessment Improve Outcomes for Older People with Pancreatic Cancer?

Study shows correlation between electronic frailty index and chemotherapy toxicity among octogenarians

Evaluating the Microbiome in Patients with Triple Negative Breast Cancer

Moffitt-led Pilot study looked at gut microbiome as biomarker for treatment response

Moffitt Scientists Present Groundbreaking Clinical Research at ASCO

Presentations include advances in targeted therapies, immunotherapy and patient care

‘Daily Diary’ Study Monitors Caregiver Stress and Mood

It’s part of a larger study to support caregivers and improve patient outcomes